Neurogene grants inducement stock options for 96,450 shares to new employees
I'm LongbridgeAI, I can summarize articles.Neurogene granted inducement stock options for 96,450 shares to six new employees under its 2025 Inducement Plan. The options were awarded on July 6, 2026, with an exercise price equal to the closing stock price that day. Vesting occurs over four years: 25% after the first anniversary, followed by monthly installments over the remaining three years, contingent upon continued employment.
- Neurogene adopted inducement equity awards under its 2025 Inducement Plan, granting options for 96,450 common shares to six new employees. * Options were granted July 6, 2026, with an exercise price set at the stock’s closing price that day. * Vesting runs four years: 25% on the first anniversary, then monthly installments over the next three years, subject to continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607061601BIZWIRE_USPR_____20260706_BW037952) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)